Long-term immunogenicity and safety of inactivated Hantaan virus vaccine (Hantavax™) in healthy adults

Hantavax™ showed a booster effect and immunogenicity lasting two years with a three-dose schedule. The neutralizing antibody response was quite poor with two primary doses, so an early booster vaccination at 2-6 months might be warranted to provide timely protection to high-risk subjects.